Ignite Creation Date:
2025-12-25 @ 1:26 AM
Ignite Modification Date:
2026-01-06 @ 7:20 PM
Study NCT ID:
NCT06617793
Status:
RECRUITING
Last Update Posted:
2025-10-23
First Post:
2024-09-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
An Open-label Study to Assess the Safety, Efficacy, and Cellular Kinetics of YTB323 in Relapsing Multiple Sclerosis
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-02-24
Start Date Type:
ACTUAL
Primary Completion Date:
2030-10-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2030-10-01
Completion Date Type:
ESTIMATED
First Submit Date:
2024-09-26
First Submit QC Date:
None
Study First Post Date:
2024-09-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-10-21
Last Update Post Date:
2025-10-23
Last Update Post Date Type:
ESTIMATED